Compile Data Set for Download or QSAR
maximum 50k data
Found 134 of ic50 data for polymerid = 49000621,49000623,49000626,49000628,49000629
TargetGlutamate receptor ionotropic, kainate 1(RAT)
University Of Copenhagen

Curated by ChEMBL
LigandPNGBDBM50399430(CHEMBL2178920)
Affinity DataIC50:  0.190nMAssay Description:Antagonist activity at rat GluK1 receptor expressed in Xenopus oocytes by two-electrode voltage-clamp at membrane potential -60 to -80 mV electrophys...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, kainate 1(RAT)
University Of Copenhagen

Curated by ChEMBL
LigandPNGBDBM50399431(CHEMBL2178919)
Affinity DataIC50:  0.280nMAssay Description:Antagonist activity at rat GluK1 receptor expressed in Xenopus oocytes by two-electrode voltage-clamp at membrane potential -60 to -80 mV electrophys...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM141505(US8921370, 126 | US9656975, 126)
Affinity DataIC50:  0.320nMAssay Description:Binding assays were performed as described in [J. A. O'Brien et al. Mol Pharmacol., 2003, 64, 731-740] with slight modifications, including that ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, kainate 1(RAT)
University Of Copenhagen

Curated by ChEMBL
LigandPNGBDBM50399430(CHEMBL2178920)
Affinity DataIC50:  0.330nMAssay Description:Antagonist activity at rat GluK1 receptor expressed in Xenopus oocytes at membrane potential -60 mV by two-electrode voltage-clamp electrophysiology ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, kainate 1(RAT)
University Of Copenhagen

Curated by ChEMBL
LigandPNGBDBM50399431(CHEMBL2178919)
Affinity DataIC50:  0.820nMAssay Description:Antagonist activity at rat GluK1 receptor expressed in Xenopus oocytes at membrane potential -60 mV by two-electrode voltage-clamp electrophysiology ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM50252922((S)-1-(2'-Amino-2'-carboxyethyl)thieno[3,2-d]pyrim...)
Affinity DataIC50:  1.90nMAssay Description:Antagonist activity at human iGluR5(Q)1b expressed in CHO-K1 cells by whole cell patch-clamp methodMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM141501(US8921370, 2 | US9656975, 2)
Affinity DataIC50:  3.70nMAssay Description:Binding assays were performed as described in [J. A. O'Brien et al. Mol Pharmacol., 2003, 64, 731-740] with slight modifications, including that ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM50252920((S)-1-[2'-Amino-2'-carboxyethyl]-5,7-dihydrothieno...)
Affinity DataIC50:  3.80nMAssay Description:Antagonist activity at human iGluR5(Q)1b expressed in CHO-K1 cells by whole cell patch-clamp methodMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM141506(US8921370, 160 | US9656975, 160)
Affinity DataIC50:  3.90nMAssay Description:Binding assays were performed as described in [J. A. O'Brien et al. Mol Pharmacol., 2003, 64, 731-740] with slight modifications, including that ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM141508(US8921370, 171 | US9656975, 171)
Affinity DataIC50:  4.70nMAssay Description:Binding assays were performed as described in [J. A. O'Brien et al. Mol Pharmacol., 2003, 64, 731-740] with slight modifications, including that ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, kainate 1(RAT)
University Of Copenhagen

Curated by ChEMBL
LigandPNGBDBM50252920((S)-1-[2'-Amino-2'-carboxyethyl]-5,7-dihydrothieno...)
Affinity DataIC50:  5.20nMAssay Description:Displacement of [3H]SYM2081 from rat recombinant iGluR5(Q)1b expressed in Sf9 cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, kainate 1(RAT)
University Of Copenhagen

Curated by ChEMBL
LigandPNGBDBM50252922((S)-1-(2'-Amino-2'-carboxyethyl)thieno[3,2-d]pyrim...)
Affinity DataIC50:  5.30nMAssay Description:Displacement of [3H]SYM2081 from rat recombinant iGluR5(Q)1b expressed in Sf9 cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM141502(US8921370, 6 | US9656975, 6)
Affinity DataIC50:  9nMAssay Description:Binding assays were performed as described in [J. A. O'Brien et al. Mol Pharmacol., 2003, 64, 731-740] with slight modifications, including that ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, kainate 1(RAT)
University Of Copenhagen

Curated by ChEMBL
LigandPNGBDBM50105843(2-Amino-N-{3-[4-(3-amino-propylamino)-butylamino]-...)
Affinity DataIC50:  19nMAssay Description:Antagonist activity at rat GluK1 receptor expressed in Xenopus oocytes at membrane potential -60 mV by two-electrode voltage-clamp electrophysiology ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM141503(US8921370, 15 | US9656975, 15)
Affinity DataIC50:  26nMAssay Description:Binding assays were performed as described in [J. A. O'Brien et al. Mol Pharmacol., 2003, 64, 731-740] with slight modifications, including that ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM141509(US8921370, 176 | US9656975, 176)
Affinity DataIC50:  33nMAssay Description:Binding assays were performed as described in [J. A. O'Brien et al. Mol Pharmacol., 2003, 64, 731-740] with slight modifications, including that ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM141504(US8921370, 36 | US9656975, 36)
Affinity DataIC50:  35nMAssay Description:Binding assays were performed as described in [J. A. O'Brien et al. Mol Pharmacol., 2003, 64, 731-740] with slight modifications, including that ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM141510(US8921370, 178 | US9656975, 178)
Affinity DataIC50:  38nMAssay Description:Binding assays were performed as described in [J. A. O'Brien et al. Mol Pharmacol., 2003, 64, 731-740] with slight modifications, including that ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, kainate 1(RAT)
University Of Copenhagen

Curated by ChEMBL
LigandPNGBDBM50002369((2S-(2alpha,3beta,4beta))-2-carboxy-4-(1-methyleth...)
Affinity DataIC50:  77nMAssay Description:Inhibitory concentration against human Adenosine A3 receptor expressed in HEK293 cells using 0.1 nM [3H]AB-MECAMore data for this Ligand-Target Pair
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM141507(US8921370, 161 | US9656975, 161)
Affinity DataIC50:  134nMAssay Description:Binding assays were performed as described in [J. A. O'Brien et al. Mol Pharmacol., 2003, 64, 731-740] with slight modifications, including that ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, kainate 1(RAT)
University Of Copenhagen

Curated by ChEMBL
LigandPNGBDBM50399433(CHEMBL2178917)
Affinity DataIC50:  164nMAssay Description:Antagonist activity at rat GluK1 receptor expressed in Xenopus oocytes at membrane potential -60 mV by two-electrode voltage-clamp electrophysiology ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM86751(CHEMBL14935 | LY 293558 | LY-293558)
Affinity DataIC50:  500nMAssay Description:Inhibition of GluK1 receptor (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM50364074(CHEMBL1950805)
Affinity DataIC50:  650nMAssay Description:Antagonist activity at human recombinant GluK1 receptor expressed in human HEK293 cells assessed as inhibition of glutamate-stimulated calcium influx...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM50185318((S)-1-(2-amino-2-carboxyethyl)-3-(2-carboxythiophe...)
Affinity DataIC50:  680nMAssay Description:Inhibition of glutamate-induced calcium influx in HEK293 cells expressing human GLUK5 by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, kainate 2(Homo sapiens (Human))
Medical University Of Lublin

Curated by ChEMBL
LigandPNGBDBM50445689(CHEMBL3104225)
Affinity DataIC50:  700nMAssay Description:Displacement of [3H]-kainate from GluK2 receptor (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM50137124(4-Chloro-2-(3-naphthalen-2-yl-ureido)-benzoic acid...)
Affinity DataIC50:  1.20E+3nMAssay Description:Antagonist activity at human homomeric GluR5 expressed in HEK293 cells assessed as inhibition of intracellular calcium concentration by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM50137141(4-Chloro-2-[3-(1H-indol-2-yl)-ureido]-benzoic acid...)
Affinity DataIC50:  1.20E+3nMAssay Description:In vitro inhibitory activity against human ionotropic glutamate receptor ionotropic kainate 1 (GluR-5) expressed in HEK293 cells.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM50137159(4-Chloro-2-[3-(3-chloro-phenyl)-ureido]-benzoic ac...)
Affinity DataIC50:  1.30E+3nMAssay Description:In vitro inhibitory activity against human ionotropic glutamate receptor ionotropic kainate 1 (GluR-5) expressed in HEK293 cells.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM50158561(2-[3-(3-bromophenyl)ureido]-4-chlorobenzenesulfoni...)
Affinity DataIC50:  1.50E+3nMAssay Description:Antagonist activity at human homomeric GluR5 expressed in HEK293 cells assessed as inhibition of intracellular calcium concentration by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM50137133(4,6-Bis-benzoylamino-isophthalic acid | CHEMBL1567...)
Affinity DataIC50:  1.60E+3nMAssay Description:In vitro inhibitory activity against human ionotropic glutamate receptor ionotropic kainate 1 (GluR-5) expressed in HEK293 cells.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM50158556(1-(3-bromophenyl)-3-[5-chloro-2-(1H-tetrazol-5-yl-...)
Affinity DataIC50:  2.00E+3nMAssay Description:Antagonist activity at human homomeric GluR5 expressed in HEK293 cells assessed as inhibition of intracellular calcium concentration by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM50137142(2-[3-(4-Bromo-phenyl)-ureido]-4-chloro-benzoic aci...)
Affinity DataIC50:  2.20E+3nMAssay Description:In vitro inhibitory activity against human ionotropic glutamate receptor ionotropic kainate 1 (GluR-5) expressed in HEK293 cells.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM50137129(4-Chloro-2-[3-(3-iodo-phenyl)-ureido]-benzoic acid...)
Affinity DataIC50:  2.20E+3nMAssay Description:In vitro inhibitory activity against human ionotropic glutamate receptor ionotropic kainate 1 (GluR-5) expressed in HEK293 cells.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, kainate 1(RAT)
University Of Copenhagen

Curated by ChEMBL
LigandPNGBDBM50399432(CHEMBL2178918)
Affinity DataIC50:  2.58E+3nMAssay Description:Antagonist activity at rat GluK1 receptor expressed in Xenopus oocytes at membrane potential -60 mV by two-electrode voltage-clamp electrophysiology ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM50158568(1-(3-bromophenyl)-3-(5-chloro-2-cyanophenyl)urea |...)
Affinity DataIC50: >3.00E+3nMAssay Description:Antagonist activity at human homomeric GluR5 expressed in HEK293 cells assessed as inhibition of intracellular calcium concentration by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM50158560(1-(5-chloro-2-nitrophenyl)-3-(3-trifluoromethylphe...)
Affinity DataIC50: >3.00E+3nMAssay Description:Antagonist activity at human homomeric GluR5 expressed in HEK293 cells assessed as inhibition of intracellular calcium concentration by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM50158566(1-(3-bromophenyl)-3-(5-chloro-2-nitrophenyl)urea |...)
Affinity DataIC50: >3.00E+3nMAssay Description:Antagonist activity at human homomeric GluR5 expressed in HEK293 cells assessed as inhibition of intracellular calcium concentration by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM50137157(4-Chloro-2-[3-(4-chloro-phenyl)-ureido]-benzoic ac...)
Affinity DataIC50:  3.10E+3nMAssay Description:In vitro inhibitory activity against human ionotropic glutamate receptor ionotropic kainate 1 (GluR-5) expressed in HEK293 cells.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM50158554(CHEMBL224688 | {2-[3-(3-bromophenyl)ureido]-4-chlo...)
Affinity DataIC50:  3.60E+3nMAssay Description:Antagonist activity at human homomeric GluR5 expressed in HEK293 cells assessed as inhibition of intracellular calcium concentration by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM50137169(2-(3-Benzo[1,3]dioxol-5-yl-ureido)-4-chloro-benzoi...)
Affinity DataIC50:  3.60E+3nMAssay Description:In vitro inhibitory activity against human ionotropic glutamate receptor ionotropic kainate 1 (GluR-5) expressed in HEK293 cells.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM50137145(4-Chloro-2-[3-(3-methoxy-phenyl)-ureido]-benzoic a...)
Affinity DataIC50:  3.70E+3nMAssay Description:In vitro inhibitory activity against human ionotropic glutamate receptor ionotropic kainate 1 (GluR-5) expressed in HEK293 cells.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM50137150(4-Chloro-2-[3-(2-trifluoromethyl-phenyl)-ureido]-b...)
Affinity DataIC50:  4.50E+3nMAssay Description:In vitro inhibitory activity against human ionotropic glutamate receptor ionotropic kainate 1 (GluR-5) expressed in HEK293 cells.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM50137153(2-[3-(2-Bromo-phenyl)-ureido]-4-chloro-benzoic aci...)
Affinity DataIC50:  4.50E+3nMAssay Description:In vitro inhibitory activity against human ionotropic glutamate receptor ionotropic kainate 1 (GluR-5) expressed in HEK293 cells.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM50158555(1-[5-chloro-2-(5-oxo-4,5-dihydro-[1,2,4]oxadiazol-...)
Affinity DataIC50:  4.60E+3nMAssay Description:Antagonist activity at human homomeric GluR5 expressed in HEK293 cells assessed as inhibition of intracellular calcium concentration by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM50137164(4-Chloro-2-[3-(4-iodo-phenyl)-ureido]-benzoic acid...)
Affinity DataIC50:  4.70E+3nMAssay Description:In vitro inhibitory activity against human ionotropic glutamate receptor ionotropic kainate 1 (GluR-5) expressed in HEK293 cells.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM50137128(4-Chloro-2-[3-(2-chloro-phenyl)-ureido]-benzoic ac...)
Affinity DataIC50:  4.70E+3nMAssay Description:In vitro inhibitory activity against human ionotropic glutamate receptor ionotropic kainate 1 (GluR-5) expressed in HEK293 cells.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM50137125(2-(3-(3-bromophenyl)ureido)-4-chlorobenzoic acid |...)
Affinity DataIC50:  4.80E+3nMAssay Description:In vitro inhibitory activity against human ionotropic glutamate receptor ionotropic kainate 1 (GluR-5) expressed in HEK293 cells.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM50137136(4-Chloro-2-[3-(4-trifluoromethyl-phenyl)-ureido]-b...)
Affinity DataIC50:  4.80E+3nMAssay Description:In vitro inhibitory activity against human ionotropic glutamate receptor ionotropic kainate 1 (GluR-5) expressed in HEK293 cells.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM50137125(2-(3-(3-bromophenyl)ureido)-4-chlorobenzoic acid |...)
Affinity DataIC50:  4.80E+3nMAssay Description:Antagonist activity at human homomeric GluR5 expressed in HEK293 cells assessed as inhibition of intracellular calcium concentration by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, kainate 1(Homo sapiens (Human))
H. Lundbeck

US Patent
LigandPNGBDBM50137149(4-Chloro-2-[3-(3-trifluoromethyl-phenyl)-ureido]-b...)
Affinity DataIC50:  5.00E+3nMAssay Description:Antagonist activity at human homomeric GluR5 expressed in HEK293 cells assessed as inhibition of intracellular calcium concentration by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 134 total ) | Next | Last >>
Jump to: